Detection of minimal residual disease in blood and bone marrow in early stage breast cancer. - Wikidata - wikimedia - TriplyDB

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.

http://www.wikidata.org/entity/Q43011834

about

Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Current Understanding of Circulating Tumor Cells - Potential Value in Malignancies of the Central Nervous System Minimal residual disease and circulating tumor cells in breast cancer Impact of the physical microenvironment on tumor progression and metastasis Microenvironmental regulation of tumor progression and metastasis Circulating tumor cells in breast cancer.Circulating tumor cells in non-metastatic triple-negative breast cancer.Monitoring the progression of metastatic breast cancer on nanoporous silica chips.Breast tumor cell detection at single cell resolution using an electrochemical impedance technique.Circulating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progression The Evolving Role of Circulating Tumor Cells in the Personalized Management of Breast Cancer: from Enumeration to Molecular Characterization.A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer Monitoring dynamic interactions between breast cancer cells and human bone tissue in a co-culture model.Clinical relevance and biology of circulating tumor cells.The dynamic change of circulating tumour cells in patients with operable breast cancer before and after chemotherapy based on a multimarker QPCR platform Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer.Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer.Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer.Circulating Tumor Cells and Recurrence After Primary Systemic Therapy in Stage III Inflammatory Breast Cancer.Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival Different prognostic value of circulating and disseminated tumor cells in primary breast cancer: Influence of bisphosphonate intake?Breast cancer as a systemic disease: a view of metastasis Heterogeneity of circulating epithelial tumour cells from individual patients with respect to expression profiles and clonal growth (sphere formation) in breast cancer.Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients.No evidence for shedding of circulating tumor cells to the peripheral venous blood as a result of mammographic breast compression Role of circulating tumor cells and disseminated tumor cells in primary breast cancer.Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.Circulating tumor cells as emerging tumor biomarkers in breast cancer.The emerging role of circulating tumor cells in breast cancer.Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies.Enrichment, detection and clinical significance of circulating tumor cells.Molecular Profiling and Significance of Circulating Tumor Cell Based Genetic Signatures.Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patients.Detection and prevalence of disseminated tumor cells from the bone marrow of early stage male breast cancer patients.Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I-III Triple-Negative Breast Cancer.Usefulness of CTC and DTC-BM Detection for Adjuvant Therapy Effects and Prognosis Prediction in Early Breast Carcinoma: Results of 8-11 Years of Follow-up Evaluation.Prognostic Value of Circulating Tumor Cells Identified Before Surgical Resection in Nonmetastatic Breast Cancer Patients.

P2860

Q26745560-CFDEA243-1E1A-4550-A3D3-16D39478741B Q26748850-D6A488EB-4077-4491-B04C-C3052076164D Q26796208-BA5D3070-9FF8-464A-9078-7D4A42E25273 Q27010152-1B359920-C726-47E9-9D9A-CAAF1B28574A Q29299789-28ADC75E-A6CD-4842-B285-F3D65D430119 Q29615504-EE3247C5-592B-44B1-83E9-893604494CB3 Q34077349-42669846-674C-446B-B659-F1986683BCBC Q34111867-776BE807-AD84-4FB0-B592-10FF875A54FE Q34234831-A1C5FB9F-2556-4508-8638-A22DED695336 Q34238076-408A6F74-286E-46E4-A93F-29098EC277F6 Q34496964-93D03A3E-DAAC-4637-91D3-E1BE5A7167DD Q34564188-C2DAB09C-A0AF-4F2A-A52D-38E4643FAA04 Q35034712-D257670F-352D-4E00-A353-D4B41417014A Q35801397-46AE52E7-C659-47EB-9325-ED44E5F3F692 Q35889548-4693F27E-3420-4FCB-B428-82729B7799B9 Q35949551-F2A5188E-59EB-4E78-9955-5814FBD1216A Q36369695-FE7DD729-B386-434B-B66E-2CD8454D5E69 Q36387861-31ABA327-5038-494C-86C7-B4B705D6190D Q36427515-9105EA77-6E19-4434-BE65-B0721607977E Q36482582-0EC770F8-9C9E-413A-83C3-C093F8282B10 Q36804888-C36C8296-847F-4305-A8EB-EB022C165203 Q36848095-94146F0C-74F3-4B65-B9AB-B840C88C4D16 Q36924468-F023D159-8091-45B6-815D-0134D945D145 Q36925557-87C6B589-FB16-48B2-9B30-67A01EBB9DFD Q37011741-F3BD9465-088E-4ABA-9844-680B49AD2F16 Q37112805-00A784E3-E956-4D0F-93B0-DED5E60E7466 Q37200498-65D09F7B-95D0-4FA4-9A1C-9FB5A378DDE4 Q37202511-ED453C1B-CF00-40B4-AB50-D1A5B4ADB768 Q37885239-C0B487B3-C11A-4692-A185-B5A66415FDDD Q37894736-ECA34F37-86B1-4854-8EC8-6F3EADA9E485 Q37908134-F0C100C0-A58A-4EF0-A625-4BE7AEA73EEE Q37978566-B4490FAE-F8A6-497A-A53B-E41DDB40B319 Q38097525-68C4F98E-F5CF-4BFD-86D9-13E968DB9D02 Q38102590-DCD2D09E-088B-4F07-8F8A-6FF6E7734537 Q38676889-7F9BF533-0C48-4893-8F9D-B27600936F34 Q38949124-6C24D76E-8884-4751-990B-8EF485CAA323 Q39002420-F7F8482E-7604-4D1C-B567-121F8D3FDF46 Q39007492-FC5262CC-0CBD-43CE-9994-4E73D3EC61A2 Q39137626-EC722779-DA1C-4E0C-81FF-A3D502DAB9E9 Q39859646-D37E1607-BB7C-4939-B7FA-12F3E4186BC5

P2860

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.

http://www.wikidata.org/entity/Q43011834

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Detection of minimal residual ...... in early stage breast cancer.

@en

Detection of minimal residual ...... in early stage breast cancer.

@nl

type

label

Detection of minimal residual ...... in early stage breast cancer.

@en

Detection of minimal residual ...... in early stage breast cancer.

@nl

prefLabel

Detection of minimal residual ...... in early stage breast cancer.

@en

Detection of minimal residual ...... in early stage breast cancer.

@nl

P1433

Q43011834-DDBDF945-D467-4875-9A23-670D1FD4EFB3

P1476

Q43011834-59938294-38CB-4268-807C-1CC03DA9E9C6

P2093

Q43011834-1FFCFE38-A48F-4919-9C10-4B8F53C3F978

Q43011834-205D022C-7F56-4D49-BDD0-415B35948574

Q43011834-373D6759-A36B-4083-9ED9-61DE6884462A

Q43011834-4B08246D-E2C8-49AF-A24B-2347081486AC

Q43011834-978B33A0-F86A-4C59-AD3B-6593DA14D8B8

Q43011834-A48F9DE3-E6EB-4FD6-BFFD-E77B9820D578

Q43011834-D5EF35F0-5943-4D13-8672-1A4A6BE65029

Q43011834-DBF94F48-2CE5-4589-8405-40AF3CA481D2

Q43011834-DF0734EC-8D49-4A68-9BB3-02400BE3CDF3

Q43011834-FA7D9662-B5CF-4E95-8A09-F054A75470E3

P2860

Q43011834-38CF28C2-AD6E-4A06-821C-4CA1C3E84D74

P304

Q43011834-0268B22C-580B-4F23-B165-3C53D0F62646

P31

Q43011834-2CD621E3-3A6B-4C85-9286-9F2BA4B20439

P356

Q43011834-D1619D18-30F7-4DB7-97FE-0C74995757C3

P407

Q43011834-7BDEE29F-AB9D-4048-B1A4-E9299F3CC645

P433

Q43011834-A987C7CD-A201-43C2-8A4D-9EDDB78B602D

P478

Q43011834-15E27600-E18C-40D8-88E1-1D8B2AE7FEE6

P50

Q43011834-54C1B98C-2A66-4FF6-93D9-5C207F63776E

P577

Q43011834-D3F6F0E5-3717-4685-ABE0-0BCC09CF1358

P5875

Q43011834-C895D0C9-F216-4CAA-9798-87ADCCE6EF8D

P698

Q43011834-E72DADFC-3E99-473F-B9F0-9E217FEEC010

P921

Q43011834-AB69674F-9D3B-4294-B16F-B3BABA39BF2A

P356

P1433

P1476

Detection of minimal residual ...... w in early stage breast cancer

@en

P2093

Anthony Lucci

http://www.w3.org/2001/XMLSchema#string

Ashutosh Lodhi

http://www.w3.org/2001/XMLSchema#string

Balraj Singh

http://www.w3.org/2001/XMLSchema#string

Carolyn S Hall

http://www.w3.org/2001/XMLSchema#string

Eleni Andreopoulou

http://www.w3.org/2001/XMLSchema#string

Hui Gao

http://www.w3.org/2001/XMLSchema#string

James Reuben

http://www.w3.org/2001/XMLSchema#string

Massimo Cristofanilli

http://www.w3.org/2001/XMLSchema#string

Savitri Krishnamurthy

http://www.w3.org/2001/XMLSchema#string

Summer Jackson

http://www.w3.org/2001/XMLSchema#string

P2860

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

P304

3330-3337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.25145

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44688659

http://www.w3.org/2001/XMLSchema#string

P698

20564098

http://www.w3.org/2001/XMLSchema#string

P921